Outperformed over 99% of Morningstar peers during my tenure on OTC fund.
OTC fund compounded at 19.3%ish per annum during my tenure.
OTC fund won 6 Lipper awards during my tenure.
Board observer at AppNexus, Jet.com, 23andMe, Dataminr, Roku, Nutanix.